Russia's CoviVac more than 80% effective against COVID-19

Developer says could produce six times more than previously planned 10 million doses a year


Reuters June 02, 2021
A view shows vials containing Russian-made vaccines against the coronavirus disease (COVID-19) during a demonstration at a regional clinical medical and rehabilitation centre in Tver, Russia May 24, 2021. Vials contain vaccines Gam-COVID-Vac or Sputnik-V developed by the Gamaleya National Center of Epidemiology and Microbiology, CoviVac produced by the Chumakov Centre and EpiVacCorona made by Vector State Research Centre of Virology and Biotechnology. PHOTO: REUTERS

Russia's third vaccine against COVID-19, CoviVac, is more than 80% effective according to preliminary data, the Interfax news agency cited the vaccine's developer as saying on Wednesday.

The Chumakov Centre could produce six times more than the previously planned 10 million doses of the vaccine a year, Interfax added.

Our Publications

Most Read

RELATED

COMMENTS

Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ